Journal Description
Tropical Medicine and Infectious Disease
Tropical Medicine and Infectious Disease
is an international, scientific, peer-reviewed, open access journal of tropical medicine and infectious disease published monthly online by MDPI. It is the official journal of the Australasian College of Tropical Medicine (ACTM) and its Joint Faculties of Travel Medicine and Expedition and Wilderness Medicine.
- Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
- High Visibility: indexed within Scopus, SCIE (Web of Science), PubMed, PMC, Embase, Informit, and other databases.
- Journal Rank: JCR - Q1 (Tropical Medicine) / CiteScore - Q2 (Public Health, Environmental and Occupational Health)
- Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 20.9 days after submission; acceptance to publication is undertaken in 4.8 days (median values for papers published in this journal in the first half of 2024).
- Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
Impact Factor:
2.8 (2023);
5-Year Impact Factor:
3.0 (2023)
Latest Articles
Transitioning Adolescents to Adult HIV Care in the United States: Implementation Lessons from the iTransition Intervention Pilot Trial
Trop. Med. Infect. Dis. 2024, 9(12), 297; https://doi.org/10.3390/tropicalmed9120297 - 3 Dec 2024
Abstract
Although every youth in pediatric/adolescent HIV care will need to transition to adult-oriented care, there are no existing evidence-based interventions to optimize health through this process. Healthcare transition poses a persistent challenge to the health of youth living with HIV, which may result
[...] Read more.
Although every youth in pediatric/adolescent HIV care will need to transition to adult-oriented care, there are no existing evidence-based interventions to optimize health through this process. Healthcare transition poses a persistent challenge to the health of youth living with HIV, which may result in gaps in care engagement, medication adherence, and viral suppression. Our process evaluation of iTransition, a multilevel mobile health (mHealth) intervention, included iterative interviews with youth, providers, and Transition Champions. These data, along with team meeting notes, highlight the important role the intervention plays in addressing healthcare transition-related challenges, positioning it to fill a critical gap for both youth and providers. It also highlights important individual (e.g., competing priorities of youth and providers), clinical (e.g., electronic health record integration), and contextual (e.g., clinical policies during COVID-19 pandemic) challenges to intervention reach and implementation. More work is needed to refine interventions to support care continuity for youth living with HIV as they transition to adult-oriented care.
Full article
(This article belongs to the Special Issue Adolescent HIV Care and Transition Strategies: Challenges, Outcomes, and Interventions)
Open AccessOpinion
Integrating Community Engagement in Zero Leprosy Efforts: A Pathway to Sustainable Early Detection, Control and Elimination
by
Anil Fastenau, Matthew Willis, Constanze Vettel, Sophie C. W. Stuetzle, Srilekha Penna, Priyanka Chahal, Fabian Schlumberger, Mowmita Basak Mow, Ngozi Ekeke, Joseph Ngozi Chukwu and Patricia D. Deps
Trop. Med. Infect. Dis. 2024, 9(12), 296; https://doi.org/10.3390/tropicalmed9120296 - 3 Dec 2024
Abstract
Community engagement has emerged as a critical component in the effective control and elimination of neglected tropical diseases (NTDs), particularly in regions with persistent stigma and limited healthcare access. Drawing on case studies from Brazil, India, and Nigeria, this opinion piece explores how
[...] Read more.
Community engagement has emerged as a critical component in the effective control and elimination of neglected tropical diseases (NTDs), particularly in regions with persistent stigma and limited healthcare access. Drawing on case studies from Brazil, India, and Nigeria, this opinion piece explores how community-driven initiatives have successfully improved leprosy awareness, reduced stigma, and fostered early case detection and treatment adherence. The importance of culturally sensitive, inclusive approaches in health education and stigma reduction campaigns is highlighted, emphasizing the potential for community engagement to enhance national leprosy programs and contribute to the World Health Organization’s Zero Leprosy Strategy. By examining these examples, this article illustrates how integrating community participation into leprosy control and elimination programs can drive sustainable outcomes for achieving Zero Leprosy, even in resource-limited settings.
Full article
(This article belongs to the Special Issue Towards Zero Leprosy: Epidemiology and Prevention Strategy)
Open AccessArticle
Burden of Food-Borne Trematodiases in China: Trends from 1990 to 2021 and Projections to 2035
by
Yanzheng Zou, Yihu Lin, Yili Qian, Luqiu Tao, Gao Tan, Hongru Zhu, Li Pan, Xiaoli Liu, Yu He and Wei Wang
Trop. Med. Infect. Dis. 2024, 9(12), 295; https://doi.org/10.3390/tropicalmed9120295 - 3 Dec 2024
Abstract
To assess the burden of food-borne trematodiases in China from 1990 to 2021 and project the burden through 2035, data were captured from the Global Burden of Disease Study (GBD) 2021 datasets. The estimated prevalent food-borne trematodiase cases were 33.32 million (95% uncertainty
[...] Read more.
To assess the burden of food-borne trematodiases in China from 1990 to 2021 and project the burden through 2035, data were captured from the Global Burden of Disease Study (GBD) 2021 datasets. The estimated prevalent food-borne trematodiase cases were 33.32 million (95% uncertainty interval (UI): 29.25–38.35 million) in China in 2021, contributing to 768,297.4 disability-adjusted life years (DALYs) (95% UI: 383,882.8–1,367,826.1). The number of prevalent cases and DALYs declined by 9.02% and 18.11%, and a downward decline was seen in age-standardized prevalence and DALY rates (estimated annual percentage change: −0.96% and −1.21%, respectively). A higher prevalence and DALY rates were observed among males than females, and the middle-aged group bore the highest burden, while the older population showed the most rapid increase in prevalent cases and DALY numbers. Projected DALY counts and rates remain stable through 2035 using the Bayesian age–period–cohort (BAPC) model. These findings demonstrate a decline in the burden of food-borne trematodiases in China from 1990 to 2021; however, the prevalence remained high, which contributed considerably to disability and premature death. Continued control efforts and targeted interventions are essential to further reducing the burden of food-borne trematodiases in China.
Full article
(This article belongs to the Section Neglected and Emerging Tropical Diseases)
►▼
Show Figures
Figure 1
Figure 1
<p>Trends in age-standardized and age-specific prevalence and DALY rates of food-borne trematodiases in China from 1990 to 2021. (<b>A</b>) Age-standardized prevalence. (<b>B</b>) Age-standardized DALY rates. The blue lines represent values for males, and the red lines represent values for females. These lines do not represent the same values but indicate gender-specific rates for the respective measures. (<b>C</b>) Age-specific prevalence. (<b>D</b>) Age-specific DALY rates. The meanings of the blue, red, and colored lines are described in the legends on the right side of the figures. Abbreviations: DALY, disability-adjusted life year.</p> Full article ">Figure 2
<p>Age-specific prevalence and DALYs numbers and rates of food-borne trematodiases in China in 2021. (<b>A</b>) Prevalence (number of cases) and rates by age group and gender. (<b>B</b>) DALY numbers and rates by age group and gender. Abbreviations: DALYs, disability-adjusted life years. Blue lines indicate data among men, and red lines indicate data among women. The shadows indicate the 95% <span class="html-italic">CI</span>s for the prevalence and DALYs numbers and rates.</p> Full article ">Figure 3
<p>Prediction of age-standardized DALYs rates and counts for food-borne trematodiases in China from 2022 to 2035. (<b>A</b>,<b>B</b>) Both genders; (<b>C</b>,<b>D</b>) men; (<b>E</b>,<b>F</b>) women. The blue bars indicate observed values, and the red bars indicate predicted values. The shadows or error bars indicate the 95% <span class="html-italic">CI</span>s for the predicted rates and numbers. Abbreviations: DALY, disability-adjusted life years; <span class="html-italic">CI</span>, confidence interval.</p> Full article ">
<p>Trends in age-standardized and age-specific prevalence and DALY rates of food-borne trematodiases in China from 1990 to 2021. (<b>A</b>) Age-standardized prevalence. (<b>B</b>) Age-standardized DALY rates. The blue lines represent values for males, and the red lines represent values for females. These lines do not represent the same values but indicate gender-specific rates for the respective measures. (<b>C</b>) Age-specific prevalence. (<b>D</b>) Age-specific DALY rates. The meanings of the blue, red, and colored lines are described in the legends on the right side of the figures. Abbreviations: DALY, disability-adjusted life year.</p> Full article ">Figure 2
<p>Age-specific prevalence and DALYs numbers and rates of food-borne trematodiases in China in 2021. (<b>A</b>) Prevalence (number of cases) and rates by age group and gender. (<b>B</b>) DALY numbers and rates by age group and gender. Abbreviations: DALYs, disability-adjusted life years. Blue lines indicate data among men, and red lines indicate data among women. The shadows indicate the 95% <span class="html-italic">CI</span>s for the prevalence and DALYs numbers and rates.</p> Full article ">Figure 3
<p>Prediction of age-standardized DALYs rates and counts for food-borne trematodiases in China from 2022 to 2035. (<b>A</b>,<b>B</b>) Both genders; (<b>C</b>,<b>D</b>) men; (<b>E</b>,<b>F</b>) women. The blue bars indicate observed values, and the red bars indicate predicted values. The shadows or error bars indicate the 95% <span class="html-italic">CI</span>s for the predicted rates and numbers. Abbreviations: DALY, disability-adjusted life years; <span class="html-italic">CI</span>, confidence interval.</p> Full article ">
Open AccessArticle
The Trend of Tuberculosis Case Notification Rates from 1995 to 2022 by Country Income and World Health Organization Region
by
Kobto G. Koura and Anthony D. Harries
Trop. Med. Infect. Dis. 2024, 9(12), 294; https://doi.org/10.3390/tropicalmed9120294 - 2 Dec 2024
Abstract
Over the past 27 years, three major global TB control strategies have been implemented, and it is important at this stage to evaluate their impact on tuberculosis (TB) case notification rates (CNRs). This study, therefore, analyzed TB CNR trends from 1995 to 2022
[...] Read more.
Over the past 27 years, three major global TB control strategies have been implemented, and it is important at this stage to evaluate their impact on tuberculosis (TB) case notification rates (CNRs). This study, therefore, analyzed TB CNR trends from 1995 to 2022 across 208 countries and islands, using data from the WHO Global TB Programme database. Countries were classified by income level and population size based on World Bank criteria. The analysis revealed significant disparities in TB CNRs across income groups: Low-income, lower-middle-income, and upper-middle-income countries consistently reported higher CNRs compared to high-income countries. Regional analysis further demonstrated notable variations influenced by both economic and geographical factors. These findings reaffirm the strong link between TB and poverty, underscoring the need for a holistic approach to combat the disease. Efforts must extend beyond enhancing health care access and delivery to addressing the social determinants that drive TB transmission and progression.
Full article
(This article belongs to the Special Issue Tuberculosis Control in Africa and Asia)
►▼
Show Figures
Figure 1
Figure 1
<p>TB case notification at global level by incomes, 1995 to 2022.</p> Full article ">Figure 2
<p>TB CNRs in WHO African Region by incomes, 1995 to 2022.</p> Full article ">Figure 3
<p>TB CNRs in WHO Region of the Americas by incomes, 1995 to 2022.</p> Full article ">Figure 4
<p>TB CNRs in WHO Eastern Mediterranean Region by incomes, 1995 to 2022.</p> Full article ">Figure 5
<p>TB CNRs in WHO European Region by incomes, 1995 to 2022.</p> Full article ">Figure 6
<p>TB CNRs in WHO South-East Asian Region by incomes, 1995 to 2022.</p> Full article ">Figure 7
<p>TB CNRs in WHO Western Pacific Region (WPR) by incomes, 1995 to 2022.</p> Full article ">
<p>TB case notification at global level by incomes, 1995 to 2022.</p> Full article ">Figure 2
<p>TB CNRs in WHO African Region by incomes, 1995 to 2022.</p> Full article ">Figure 3
<p>TB CNRs in WHO Region of the Americas by incomes, 1995 to 2022.</p> Full article ">Figure 4
<p>TB CNRs in WHO Eastern Mediterranean Region by incomes, 1995 to 2022.</p> Full article ">Figure 5
<p>TB CNRs in WHO European Region by incomes, 1995 to 2022.</p> Full article ">Figure 6
<p>TB CNRs in WHO South-East Asian Region by incomes, 1995 to 2022.</p> Full article ">Figure 7
<p>TB CNRs in WHO Western Pacific Region (WPR) by incomes, 1995 to 2022.</p> Full article ">
Open AccessArticle
A Retrospective Study of Urinary Schistosomiasis in the Eastern Cape Province, South Africa
by
Dominic Targema Abaver
Trop. Med. Infect. Dis. 2024, 9(12), 293; https://doi.org/10.3390/tropicalmed9120293 - 30 Nov 2024
Abstract
►▼
Show Figures
Schistosomiasis is caused by infection with trematode flukes of the genus Schistosoma. More than 700 million people worldwide are estimated to be susceptible to infection. In sub-Saharan Africa, schistosomiasis is the second most widespread neglected tropical disease after malaria. This retrospective investigation evaluated
[...] Read more.
Schistosomiasis is caused by infection with trematode flukes of the genus Schistosoma. More than 700 million people worldwide are estimated to be susceptible to infection. In sub-Saharan Africa, schistosomiasis is the second most widespread neglected tropical disease after malaria. This retrospective investigation evaluated the incidence and impacts of schistosomiasis on communities across three major districts of the Eastern Cape province in South Africa using a cross-sectional retrospective observational analysis of secondary data from patients with microscopically confirmed schistosomiasis between 2019 and 2020. This study focused upon both rural and semi-urban areas, including Bizana, Butterworth, Centane, Elliotdale, Flagstaff, Idutywa, Lusikisiki, Libode, Mqanduli, Port St. Johns, Willowvale, and Mthatha. Data were obtained from three districts—Alfred Nzo, Amatole, and OR Tambo—covering both rural and semi-urban regions. This study included patients of all ages who submitted urine samples for schistosomiasis testing in the specified districts. A simple random sampling method was used to select 337 clinical records from the National Health Laboratory Service (NHLS) of Mthatha. Hospital records from the NHLS Microbiology Department of Mthatha were analyzed. St Barnabas Laboratory had the highest frequency of cases (34.1%), followed by Greenville Depot (17.8%) and Willowvale Laboratory (11.3%). Most cases were in the 10–19 age group (63.4%), followed by those under 10 years of age (24.9%). Male patients constituted 76.4% of the cases, while female patients accounted for 23.6%. Viable ova were observed in 98.2% of the samples. This study highlights a significant prevalence of schistosomiasis in the Eastern Cape province, with a higher incidence in rural areas and among males aged 10–19. These findings underscore the need for targeted public health interventions and continuous monitoring to control and prevent schistosomiasis in this region.
Full article
Figure 1
Figure 1
<p>Geographic distribution of viable ova observed across locations, with longitude and latitude coordinates indicating the sampling sites.</p> Full article ">Figure 2
<p>Geo-mapping of <span class="html-italic">Schistosoma haematobium</span> in the Eastern Cape of South Africa.</p> Full article ">
<p>Geographic distribution of viable ova observed across locations, with longitude and latitude coordinates indicating the sampling sites.</p> Full article ">Figure 2
<p>Geo-mapping of <span class="html-italic">Schistosoma haematobium</span> in the Eastern Cape of South Africa.</p> Full article ">
Open AccessReview
Evolving Landscape of Sickle Cell Anemia Management in Africa: A Critical Review
by
Hazel W. Musuka, Patrick Gad Iradukunda, Oscar Mano, Eric Saramba, Pierre Gashema, Enos Moyo and Tafadzwa Dzinamarira
Trop. Med. Infect. Dis. 2024, 9(12), 292; https://doi.org/10.3390/tropicalmed9120292 - 29 Nov 2024
Abstract
Sickle cell disease (SCD) is a prevalent inherited blood disorder, particularly affecting populations in Africa. This review examined the disease’s burden, its diverse clinical presentations, and the challenges associated with its management in African settings. Africa bears a significant burden of SCD, with
[...] Read more.
Sickle cell disease (SCD) is a prevalent inherited blood disorder, particularly affecting populations in Africa. This review examined the disease’s burden, its diverse clinical presentations, and the challenges associated with its management in African settings. Africa bears a significant burden of SCD, with prevalence varying across countries and age groups. Newborn screening programs have highlighted the high prevalence of SCD at birth, emphasizing the need for early diagnosis and intervention. The clinical manifestations of SCD in Africa are multifaceted, encompassing acute complications like vaso-occlusive crises, acute chest syndrome, and stroke, as well as chronic complications such as organ damage and leg ulcers. Biological factors, including fetal hemoglobin levels, and demographic factors, like age and sex, influence disease severity and outcomes. The management of SCD in Africa faces numerous challenges. Limited access to resources, including diagnostic tools, medications, and trained healthcare professionals, hinders optimal care. The high cost of advanced therapies further restricts patient access. Cultural stigma and a lack of awareness create additional barriers to effective management. To address these challenges, early diagnosis through newborn screening programs and point-of-care testing is crucial. Comprehensive care models, including hydroxyurea therapy, pain management, and patient education, are essential for improving outcomes. Collaboration with international networks and leveraging local resources can enhance the sustainability of SCD programs. In conclusion, SCD significantly impacts African populations. Overcoming the challenges associated with its management requires addressing resource limitations, affordability issues, and cultural barriers. Early diagnosis, comprehensive care models, and ongoing research focused on affordability and accessibility are crucial for improving the lives of individuals living with SCD in Africa.
Full article
Open AccessArticle
Mortality Profile of Deaths Related to Infective Endocarditis in Brazil and Regions: A Population-Based Analysis of Death Records
by
João Vitor Fazzio de Andrade Cordeiro, Letícia Martins Raposo and Paulo Henrique Godoy
Trop. Med. Infect. Dis. 2024, 9(12), 291; https://doi.org/10.3390/tropicalmed9120291 - 29 Nov 2024
Abstract
Background: Studies of infective endocarditis (IE) are generally limited to institutions, underlining the need for more comprehensive epidemiological research. Objective: The aim of this study was to determine the mortality profile of IE-related deaths and related causes in Brazil at the national level
[...] Read more.
Background: Studies of infective endocarditis (IE) are generally limited to institutions, underlining the need for more comprehensive epidemiological research. Objective: The aim of this study was to determine the mortality profile of IE-related deaths and related causes in Brazil at the national level and across regions. Method: We conducted a population-based study using data from the country’s mortality information system for the period 2000 to 2019. We identified IE-related deaths and related causes based on the ICD-10 codes. Cluster analysis was performed to determine the relationship between the variables. Results: There were 52,055 IE-related deaths during the study period. Deaths occurred predominantly among men and people aged between 60 and 79 years. The Southeast accounted for the largest proportion of deaths. The most frequent ICD-10 chapter mentioned in relation to IE-related deaths was diseases of the circulatory system. We identified three distinctive profiles: 1—an age of 80 years and over and women, where the most frequent chapters were endocrine, circulatory and metabolic diseases and the South and Southeast accounted for the largest proportion of deaths; 2—an age between 30 and 79 years and men, where the most frequent chapters were infectious and genitourinary diseases and the South and Southeast accounted for the largest proportion of deaths; and 3—an age between 0 and 29 years without any difference between sexes, where the most frequent chapter was diseases of the respiratory system and the North, Northeast and Midwest accounted for the largest proportion of deaths. Conclusions: The findings of the cluster analysis revealed distinctive IE-related mortality profiles, indicating regional differences.
Full article
(This article belongs to the Special Issue Highlights in Infective Endocarditis)
►▼
Show Figures
Figure 1
Figure 1
<p>Other causes related to IE-related deaths by ICD-10 chapter. Brazil and regions, 2000 to 2019.</p> Full article ">Figure 2
<p>Mortality profile of IE-related deaths by cluster based on hierarchical clustering of the principal components detected by multiple correspondence analysis.</p> Full article ">
<p>Other causes related to IE-related deaths by ICD-10 chapter. Brazil and regions, 2000 to 2019.</p> Full article ">Figure 2
<p>Mortality profile of IE-related deaths by cluster based on hierarchical clustering of the principal components detected by multiple correspondence analysis.</p> Full article ">
Open AccessArticle
Trend and Factors Associated with Medical–Surgical Complications in Patients Discharged from Leprosy Multidrug Therapy at the Specialized Regional Hospital in Macenta, Guinea, from 2012 to 2021
by
Jean Hébélamou, Fassou Mathias Grovogui, Hawa Manet, Lavilé Povogui, Ismael Béavogui, Karifa Kourouma, Abdoulaye Sow and Alexandre Delamou
Trop. Med. Infect. Dis. 2024, 9(12), 290; https://doi.org/10.3390/tropicalmed9120290 - 28 Nov 2024
Abstract
This study analyzed the trend and factors associated with medical–surgical complications in patients discharged from leprosy multidrug therapy at the Centre Hospitalier Régional Spécialisé (CHRS), in Macenta, Republic of Guinea. This was a retro 2012 (n = 54) and 2013 (n
[...] Read more.
This study analyzed the trend and factors associated with medical–surgical complications in patients discharged from leprosy multidrug therapy at the Centre Hospitalier Régional Spécialisé (CHRS), in Macenta, Republic of Guinea. This was a retro 2012 (n = 54) and 2013 (n = 35) and then a slight decrease between 2014 (n = 34) and 2017 (n = 26). From 2019 (n = 18) to 2021 (n = 1), a significant d spective study using routine secondary data from 2012 to 2021. The most represented age group ranged from 25 to 59 years (73.8%), with a male predominance of 72.6%. Farmers represented 60.7% of the patients, 74.5% of the patients had plantar wounds, and 48.8% resided in the N’zerekore region. A trend analysis showed an overall significant decrease in the number of patients with complications between ecline was found. In the patients with leprosy reactions, there was a reduction in numbers from 48 in 2012 to 2 in 2014, with a predominance in men. There were significant associations between region, plantar perforation disease (p = 0.013), and physical disability (p = 0.029) and between year and leprosy reaction after the cure (p < 0.001). In summary, there was a high proportion of patients with plantar ulcers, which predominantly affected farmers, and a significant proportion with leprosy reactions and physical disabilities. Community awareness around leprosy and capacity building of the providers in terms of appropriate management may contribute to improving patients’ quality of life.
Full article
(This article belongs to the Special Issue Insights on Neglected Tropical Diseases in West Africa)
►▼
Show Figures
Figure 1
Figure 1
<p>Trends in medical and surgical complications (overall and by gender) in patients discharged from leprosy multidrug therapy at the CHRS in Macenta, Guinea, between 2012 and 2021. (<b>a</b>) Overall reduction in complication rates between 2012 and 2021; (<b>b</b>) Decrease in cases of leprosy reactions between 2012 and 2014; (<b>c</b>,<b>d</b>) Low incidence of palmar and leg ulcers. <sup>a</sup> End of free care for leprosy and its complications at the CHRS in Macenta.</p> Full article ">
<p>Trends in medical and surgical complications (overall and by gender) in patients discharged from leprosy multidrug therapy at the CHRS in Macenta, Guinea, between 2012 and 2021. (<b>a</b>) Overall reduction in complication rates between 2012 and 2021; (<b>b</b>) Decrease in cases of leprosy reactions between 2012 and 2014; (<b>c</b>,<b>d</b>) Low incidence of palmar and leg ulcers. <sup>a</sup> End of free care for leprosy and its complications at the CHRS in Macenta.</p> Full article ">
Open AccessArticle
Intervention to Prevent Recurrent Intestinal Parasitic Infections in People Living with HIV in Selected Parts of Eastern Cape, South Africa
by
Ifeoma Anozie, Mojisola Clara Hosu, Teke Apalata and Dominic T. Abaver
Trop. Med. Infect. Dis. 2024, 9(12), 289; https://doi.org/10.3390/tropicalmed9120289 - 27 Nov 2024
Abstract
Interactions between parasites and hosts are not fully understood, though the dynamic pattern of infection and reinfection in humans varies with different demographic variables and behavioral changes. A community-based non-equivalent control group post-test-only design, an aspect of quasi-experimental design (QED), was carried out
[...] Read more.
Interactions between parasites and hosts are not fully understood, though the dynamic pattern of infection and reinfection in humans varies with different demographic variables and behavioral changes. A community-based non-equivalent control group post-test-only design, an aspect of quasi-experimental design (QED), was carried out between March 2019 and February 2020. For the extraction of data from respondents, structural questionnaires were filled. Their CD4 count and viral load from the database of the National Health Laboratory Services, Mthatha were recorded. The method applied for the identification of intestinal parasites was a direct examination of the stool and the use of concentration methods. The post-test analysis showed that the intervention sites that received THEdS (Treatment, Health education, and Sanitation) bundle had a cure proportion of 60% and a re-infection proportion of 40%. The post-test results on control sites (treatment-only group) showed that the cure proportion was 51.4% and the re-infection proportion was 48.6%. The viral load significantly reduced from 377 to 44 copies/mL with a significant increment in CD4 count from 244 to 573 (cells µL) and (p-value) = 0.002. The combination of THEdS is an effective measure to reduce infection and reinfection of intestinal parasites. The THEdS bundle is a sustainable control and prevention method for the control of helminthes and protozoan associated with unsanitary environment and poor personal hygiene among immune-compromised individuals like HIV/AIDS patients.
Full article
Open AccessArticle
Identification of Anti-Tuberculosis Drugs Targeting DNA Gyrase A and Serine/Threonine Protein Kinase PknB: A Machine Learning-Assisted Drug-Repurposing Approach
by
Dongwoo Lee, Md Ataul Islam, Sathishkumar Natarajan, Dawood Babu Dudekula, Hoyong Chung, Junhyung Park and Bermseok Oh
Trop. Med. Infect. Dis. 2024, 9(12), 288; https://doi.org/10.3390/tropicalmed9120288 - 25 Nov 2024
Abstract
Tuberculosis (TB) is a global health challenge associated with considerable levels of illness and mortality worldwide. The development of innovative therapeutic strategies is crucial to combat the rise of drug-resistant TB strains. DNA Gyrase A (GyrA) and serine/threonine protein kinase (PknB) are promising
[...] Read more.
Tuberculosis (TB) is a global health challenge associated with considerable levels of illness and mortality worldwide. The development of innovative therapeutic strategies is crucial to combat the rise of drug-resistant TB strains. DNA Gyrase A (GyrA) and serine/threonine protein kinase (PknB) are promising targets for new TB medications. This study employed techniques such as similarity searches, molecular docking analyses, machine learning (ML)-driven absolute binding-free energy calculations, and molecular dynamics (MD) simulations to find potential drug candidates. By combining ligand- and structure-based methods with ML principles and MD simulations, a novel strategy was proposed for identifying small molecules. Drugs with structural similarities to existing TB therapies were assessed for their binding affinity to GyrA and PknB through various docking approaches and ML-based predictions. A detailed analysis identified six promising compounds for each target, such as DB00199, DB01220, DB06827, DB11753, DB14631, and DB14703 for GyrA; and DB00547, DB00615, DB06827, DB14644, DB11753, and DB14703 for PknB. Notably, DB11753 and DB14703 show significant potential for both targets. Furthermore, MD simulations’ statistical metrics confirm the drug–target complexes’ stability, with MM-GBSA analyses underscoring their strong binding affinity, indicating their promise for TB treatment even though they were not initially designed for this disease.
Full article
(This article belongs to the Special Issue Biomarkers, Diagnostic, and Therapeutic Approaches for Mycobacterial Diseases)
►▼
Show Figures
Graphical abstract
Graphical abstract
Full article ">Figure 1
<p>Workflow of the drug-repurposing for GyrA and PknB.</p> Full article ">Figure 2
<p>The binding energy of selected 45 molecules from similarity search. (<b>A</b>) Binding energy using ADV, (<b>B</b>) binding energy using PLANTS, and (<b>C</b>) binding affinity from KDeep. Green: DNA Gyrase, Orange: PknB.</p> Full article ">Figure 3
<p>A two-dimensional representation of the final selected drugs for GyrA (DB00199, DB01220, DB06827, DB11753, DB14631, and DB14703) and PknB (DB00547, DB00615, DB06827, DB14644, DB11753, and DB14703).</p> Full article ">Figure 4
<p>Binding interactions profile of the selected drug molecule with (<b>A</b>) GyrA and (<b>B</b>) PknB. Pink: Drug candidates, Blue: Targets.</p> Full article ">Figure 5
<p>Binding mode proposed drug molecules at (<b>A</b>) GyrA and (<b>B</b>) PknB.</p> Full article ">Figure 6
<p>Protein backbone RMSD of (<b>A</b>) GyrA and (<b>B</b>) PknB bound with respective final drug molecules.</p> Full article ">Figure 7
<p>Ligand RMSD of proposed drug molecules bound with (<b>A</b>) Gyrase A and (<b>B</b>) PknB.</p> Full article ">Figure 8
<p>Root-mean-square fluctuation of (<b>A</b>) DNA GyrA and (<b>B</b>) PknB bound with respective proposed drug molecules.</p> Full article ">Figure 9
<p>The radius of gyration of (<b>A</b>) GyrA and (<b>B</b>) PknB bound with proposed respective drug molecules.</p> Full article ">Figure 10
<p>Intermolecular hydrogen bonds between (<b>A</b>) GyrA and (<b>B</b>) PknB with respective proposed drug molecules.</p> Full article ">Figure 11
<p>Free energy landscape of (<b>A</b>) GyrA and (<b>B</b>) PknB bound with final drug molecules.</p> Full article ">
Full article ">Figure 1
<p>Workflow of the drug-repurposing for GyrA and PknB.</p> Full article ">Figure 2
<p>The binding energy of selected 45 molecules from similarity search. (<b>A</b>) Binding energy using ADV, (<b>B</b>) binding energy using PLANTS, and (<b>C</b>) binding affinity from KDeep. Green: DNA Gyrase, Orange: PknB.</p> Full article ">Figure 3
<p>A two-dimensional representation of the final selected drugs for GyrA (DB00199, DB01220, DB06827, DB11753, DB14631, and DB14703) and PknB (DB00547, DB00615, DB06827, DB14644, DB11753, and DB14703).</p> Full article ">Figure 4
<p>Binding interactions profile of the selected drug molecule with (<b>A</b>) GyrA and (<b>B</b>) PknB. Pink: Drug candidates, Blue: Targets.</p> Full article ">Figure 5
<p>Binding mode proposed drug molecules at (<b>A</b>) GyrA and (<b>B</b>) PknB.</p> Full article ">Figure 6
<p>Protein backbone RMSD of (<b>A</b>) GyrA and (<b>B</b>) PknB bound with respective final drug molecules.</p> Full article ">Figure 7
<p>Ligand RMSD of proposed drug molecules bound with (<b>A</b>) Gyrase A and (<b>B</b>) PknB.</p> Full article ">Figure 8
<p>Root-mean-square fluctuation of (<b>A</b>) DNA GyrA and (<b>B</b>) PknB bound with respective proposed drug molecules.</p> Full article ">Figure 9
<p>The radius of gyration of (<b>A</b>) GyrA and (<b>B</b>) PknB bound with proposed respective drug molecules.</p> Full article ">Figure 10
<p>Intermolecular hydrogen bonds between (<b>A</b>) GyrA and (<b>B</b>) PknB with respective proposed drug molecules.</p> Full article ">Figure 11
<p>Free energy landscape of (<b>A</b>) GyrA and (<b>B</b>) PknB bound with final drug molecules.</p> Full article ">
Open AccessArticle
Gender and Intersecting Barriers and Facilitators to Access the HIV Cascade of Care in Manitoba, Canada, Before and During the COVID-19 Pandemic: A Qualitative Study
by
Enrique Villacis-Alvarez, Cheryl Sobie, Katharina Maier, Margaret Lavallee, Chantal Daniels, Heather Pashe, Joel Baliddawa, Nikki Daniels, Rebecca Murdock, Robert Russell, Clara Dan, Freda Woodhouse, Susie Cusson, Lisa Patrick, Marj Schenkels, Michael Payne, Ken Kasper, Lauren J. MacKenzie, Laurie Ireland, Kimberly Templeton, Kathleen Deering, Margaret Haworth-Brockman, Yoav Keynan and Zulma Vanessa Ruedaadd
Show full author list
remove
Hide full author list
Trop. Med. Infect. Dis. 2024, 9(12), 287; https://doi.org/10.3390/tropicalmed9120287 - 25 Nov 2024
Abstract
Marginalized groups in Manitoba, Canada, especially females and people who inject drugs, are overrepresented in new HIV diagnoses and disproportionately affected by HIV and structural disadvantages. Informed by syndemic theory, our aim was to understand people living with HIV’s (PLHIV) gendered and intersecting
[...] Read more.
Marginalized groups in Manitoba, Canada, especially females and people who inject drugs, are overrepresented in new HIV diagnoses and disproportionately affected by HIV and structural disadvantages. Informed by syndemic theory, our aim was to understand people living with HIV’s (PLHIV) gendered and intersecting barriers and facilitators across the cascade of HIV care before and during the COVID-19 pandemic. This study was co-designed and co-led alongside people with lived experience and a research advisory committee. We employed semi-structured interviews with thirty-two participants and three questionnaires. Interviews were audio-recorded, transcribed, and coded, and descriptive statistics were performed on the first two questionnaires. Qualitative data analysis used thematic analysis and focused on identifying categories (individual, healthcare, and social/structural) related to the barriers and facilitators to HIV care. A total of 32 PLHIV completed this study and over 70% of females and 50% of males reported severe and moderate sexual abuse among other traumatic childhood experiences. Barriers to accessing or continuing in the cascade of HIV care included navigating the initial shock of receiving an HIV diagnosis, mental health challenges and inaccessible supports, substance use, violence (including intimate partner), internalized and enacted compounded stigma related to houselessness and substance use, discrimination by primary care service providers and social networks, lack of preventative and social supports, lack of accessible housing, and programmatic issues. COVID-19 increased mental health problems and disrupted relationships with HIV service providers and peers living with HIV. Facilitators to HIV care included stopping substance use, caring service providers particularly during HIV diagnosis, welcoming healthcare environments, social opportunities and integrated supports, and supportive social networks. Women, men, and non-binary PLHIV experience interconnected factors complicating their experiences with HIV care. Interventions should consider holistic, person-centered, and trauma-informed care options to address the barriers found in this research and appropriately serve PLHIV.
Full article
(This article belongs to the Special Issue An Update on Syndemics)
►▼
Show Figures
Figure 1
Figure 1
<p>Data collection process. Our approach to inviting people living with HIV to participate in the research project is grounded in cultural safety, trauma-informed care, and harm reduction.</p> Full article ">Figure 2
<p>Severity of trauma for each of type of childhood trauma experienced by people living with HIV in Manitoba by sex (<b>A</b>) and gender (<b>B</b>). Severity score of trauma: none, low, moderate, and severe. Type of childhood trauma: emotional, physical and sexual abuse, and emotional and physical neglect.</p> Full article ">Figure 3
<p>Barriers to HIV care in Manitoba. Model of understanding the interconnected barriers in HIV care experienced by people living with HIV in Manitoba.</p> Full article ">Figure 4
<p>Barriers and facilitators to HIV care in Manitoba. Facilitators and barriers across an extended cascade of HIV care.</p> Full article ">
<p>Data collection process. Our approach to inviting people living with HIV to participate in the research project is grounded in cultural safety, trauma-informed care, and harm reduction.</p> Full article ">Figure 2
<p>Severity of trauma for each of type of childhood trauma experienced by people living with HIV in Manitoba by sex (<b>A</b>) and gender (<b>B</b>). Severity score of trauma: none, low, moderate, and severe. Type of childhood trauma: emotional, physical and sexual abuse, and emotional and physical neglect.</p> Full article ">Figure 3
<p>Barriers to HIV care in Manitoba. Model of understanding the interconnected barriers in HIV care experienced by people living with HIV in Manitoba.</p> Full article ">Figure 4
<p>Barriers and facilitators to HIV care in Manitoba. Facilitators and barriers across an extended cascade of HIV care.</p> Full article ">
Open AccessArticle
Impact of COVID-19 Vaccination in Thailand: Averted Deaths and Severe Infections Across Age Groups
by
Chaiwat Wilasang, Pikkanet Suttirat, Dhammika Leshan Wannigama, Mohan Amarasiri, Sudarat Chadsuthi and Charin Modchang
Trop. Med. Infect. Dis. 2024, 9(12), 286; https://doi.org/10.3390/tropicalmed9120286 - 22 Nov 2024
Abstract
The COVID-19 pandemic has underscored the pivotal role of vaccines in mitigating the devastating impact of the virus. In Thailand, the vaccination campaign against SARS-CoV-2 began on 28 February 2021, initially prioritizing healthcare professionals before expanding into a nationwide effort on 7 June
[...] Read more.
The COVID-19 pandemic has underscored the pivotal role of vaccines in mitigating the devastating impact of the virus. In Thailand, the vaccination campaign against SARS-CoV-2 began on 28 February 2021, initially prioritizing healthcare professionals before expanding into a nationwide effort on 7 June 2021. This study employs a mathematical model of COVID-19 transmission with vaccination to analyze the impact of Thailand’s COVID-19 vaccination program from 1 March 2021 to 31 December 2022. We specifically assess the potential loss of lives and occurrence of severe infections across various age groups in a hypothetical scenario where vaccines were not administered. By fitting our model with officially reported COVID-19 death data, our analysis reveals that vaccination efforts prevented a total of 300,234 deaths (95% confidence interval: 295,938–304,349) and averted 1.60 million severe COVID-19 infections (95% confidence interval: 1.54–1.65 million). Notably, the elderly population over 80 years old benefited the most from vaccination, with an estimated 84,518 lives saved, constituting 4.28% of this age group. Furthermore, individuals aged between 70 and 74 years experienced the highest reduction in severe infections, with vaccination potentially preventing 8.35% of this age bracket from developing severe COVID-19.
Full article
(This article belongs to the Section Infectious Diseases)
►▼
Show Figures
Figure 1
Figure 1
<p>Baseline model fitting and validation of the model’s accuracy. (<b>a</b>) Comparison of reported daily deaths (black dots) and daily death counts generated by the baseline model (red line). The baseline model effectively captures the trends and peaks in COVID-19 mortality in Thailand. The shaded area represents the 95% partial likelihood-based confidence interval, indicating the uncertainty in the model estimates. (<b>b</b>) Scatter plot comparing the estimated deaths from the baseline model (x-axis) and the reported deaths (y-axis). Each blue dot represents a data point from the study period. The black line shows the linear regression between the estimated and reported deaths, with an R-square value of 0.9686.</p> Full article ">Figure 2
<p>Simulated COVID-19 deaths in Thailand in a hypothetical scenario without vaccination. This graph shows the hypothetical daily death toll from 1 March 2020 to 31 December 2022, assuming no vaccines were administered throughout the pandemic. In this simulated scenario, the cumulative number of COVID-19 fatalities reaches 333,886, nearly ten times higher than the actual reported deaths during this period. The model predicts a dramatic surge in mortality beginning in early June 2021, coinciding with the emergence and rapid spread of the highly transmissible Delta variant in Thailand. Without the mitigating effects of vaccination, the daily death count peaks at 6061 on 3 November 2021, highlighting the crucial role of vaccines in preventing such catastrophic outcomes.</p> Full article ">Figure 3
<p>Impact of COVID-19 vaccination on mortality in Thailand. (<b>a</b>) The green line depicts the weekly vaccine doses administered in Thailand from 1 March 2021 to 31 December 2022. A substantial increase in vaccination rates is evident between July and November 2021, with a peak of 5.59 million doses per week in October 2021. This surge in vaccination coincides with a decline in reported daily deaths (black dots), highlighting the effectiveness of the vaccination campaign in reducing COVID-19 mortality. (<b>b</b>) Averted deaths due to vaccination, calculated as the difference between the projected deaths in the baseline model and a hypothetical scenario without vaccination. The graph illustrates the substantial number of lives saved by the vaccination efforts, particularly during the peak of the Delta variant’s transmission. The shaded areas represent the periods of dominance for different SARS-CoV-2 variants in Thailand: the Ancestral strain (1 March 2020 to 31 March 2021), Alpha variant (1 April 2021 to 7 June 2021), Delta variant (8 June 2021 to 30 November 2021), and Omicron variant (1 December 2021 to 31 December 2022) [<a href="#B18-tropicalmed-09-00286" class="html-bibr">18</a>].</p> Full article ">Figure 4
<p>Age-stratified impact of COVID-19 vaccination on averted deaths and severe cases in Thailand. (<b>a</b>) The bar graph illustrates the number of lives saved across different age groups due to vaccination efforts from 1 March 2021 to 31 December 2022. The number above each bar represents the proportion of lives saved relative to the total population within each age group. The elderly population, particularly those over 80 years old, benefited the most from vaccination, with 84,518 deaths averted, constituting 4.28% of this age group. (<b>b</b>) The bar graph depicts the number of severe COVID-19 cases prevented by vaccination across various age groups. The number above each bar indicates the percentage of cases that were prevented from developing severe infections relative to the total population in each age group. Individuals aged between 70 and 74 years experienced the highest reduction in severe cases, with vaccination potentially preventing 8.35% of this age bracket from severe COVID-19.</p> Full article ">
<p>Baseline model fitting and validation of the model’s accuracy. (<b>a</b>) Comparison of reported daily deaths (black dots) and daily death counts generated by the baseline model (red line). The baseline model effectively captures the trends and peaks in COVID-19 mortality in Thailand. The shaded area represents the 95% partial likelihood-based confidence interval, indicating the uncertainty in the model estimates. (<b>b</b>) Scatter plot comparing the estimated deaths from the baseline model (x-axis) and the reported deaths (y-axis). Each blue dot represents a data point from the study period. The black line shows the linear regression between the estimated and reported deaths, with an R-square value of 0.9686.</p> Full article ">Figure 2
<p>Simulated COVID-19 deaths in Thailand in a hypothetical scenario without vaccination. This graph shows the hypothetical daily death toll from 1 March 2020 to 31 December 2022, assuming no vaccines were administered throughout the pandemic. In this simulated scenario, the cumulative number of COVID-19 fatalities reaches 333,886, nearly ten times higher than the actual reported deaths during this period. The model predicts a dramatic surge in mortality beginning in early June 2021, coinciding with the emergence and rapid spread of the highly transmissible Delta variant in Thailand. Without the mitigating effects of vaccination, the daily death count peaks at 6061 on 3 November 2021, highlighting the crucial role of vaccines in preventing such catastrophic outcomes.</p> Full article ">Figure 3
<p>Impact of COVID-19 vaccination on mortality in Thailand. (<b>a</b>) The green line depicts the weekly vaccine doses administered in Thailand from 1 March 2021 to 31 December 2022. A substantial increase in vaccination rates is evident between July and November 2021, with a peak of 5.59 million doses per week in October 2021. This surge in vaccination coincides with a decline in reported daily deaths (black dots), highlighting the effectiveness of the vaccination campaign in reducing COVID-19 mortality. (<b>b</b>) Averted deaths due to vaccination, calculated as the difference between the projected deaths in the baseline model and a hypothetical scenario without vaccination. The graph illustrates the substantial number of lives saved by the vaccination efforts, particularly during the peak of the Delta variant’s transmission. The shaded areas represent the periods of dominance for different SARS-CoV-2 variants in Thailand: the Ancestral strain (1 March 2020 to 31 March 2021), Alpha variant (1 April 2021 to 7 June 2021), Delta variant (8 June 2021 to 30 November 2021), and Omicron variant (1 December 2021 to 31 December 2022) [<a href="#B18-tropicalmed-09-00286" class="html-bibr">18</a>].</p> Full article ">Figure 4
<p>Age-stratified impact of COVID-19 vaccination on averted deaths and severe cases in Thailand. (<b>a</b>) The bar graph illustrates the number of lives saved across different age groups due to vaccination efforts from 1 March 2021 to 31 December 2022. The number above each bar represents the proportion of lives saved relative to the total population within each age group. The elderly population, particularly those over 80 years old, benefited the most from vaccination, with 84,518 deaths averted, constituting 4.28% of this age group. (<b>b</b>) The bar graph depicts the number of severe COVID-19 cases prevented by vaccination across various age groups. The number above each bar indicates the percentage of cases that were prevented from developing severe infections relative to the total population in each age group. Individuals aged between 70 and 74 years experienced the highest reduction in severe cases, with vaccination potentially preventing 8.35% of this age bracket from severe COVID-19.</p> Full article ">
Open AccessCase Report
The Challenge of Bacterial Strain Identification: Leptospira interrogans Serovars Australis in a Dog and Long-Term Clinical Follow-Up
by
Tommaso Furlanello, Elisa Mazzotta, Cristina Bertasio, Mario D’Incau, Laura Bellinati, Laura Lucchese and Alda Natale
Trop. Med. Infect. Dis. 2024, 9(12), 285; https://doi.org/10.3390/tropicalmed9120285 - 22 Nov 2024
Abstract
Leptospirosis is a widespread disease throughout the world, presenting in severe clinical forms in dogs. The pathogenicity of the different serovars in field infections is not fully documented, and clinical diagnosis is often limited to a combination of serological tests and molecular analyses.
[...] Read more.
Leptospirosis is a widespread disease throughout the world, presenting in severe clinical forms in dogs. The pathogenicity of the different serovars in field infections is not fully documented, and clinical diagnosis is often limited to a combination of serological tests and molecular analyses. The latter, although a fundamental tool, cannot identify the infecting strain without further analysis. This study reports the use of various indirect (microscopic agglutination test, MAT) and direct (microbiological culture, real-time PCR) laboratory techniques, followed by typing protocols (Multi-locus Sequence Typing (MLST), Multiple Loci Variable number tandem repeat Analysis (MLVA), serotyping) that allowed for the identification of the Leptospira serovar Australis in a symptomatic and previously vaccinated dog (vaccine containing heterologous strains). This study reports long-term clinical follow-up (0–640 days) and describes the possible role of the infection in the development of chronic renal failure. This study aims to highlight how a combination of different techniques can be useful to better characterise the environmental circulation of zoonotic agents. Therefore, the identification and isolation of circulating L. strains would facilitate the updating of epidemiological data, enhance the knowledge of pathogenicity and long-term clinical effects, and provide a valuable resource for improving the efficacy of a specific serovar vaccination.
Full article
(This article belongs to the Special Issue Neglected Zoonotic Diseases: Advances in Leptospirosis in Livestock and Companion Animals)
Open AccessReview
Genotyping and Characterizing Plasmodium falciparum to Reveal Genetic Diversity and Multiplicity of Infection by Merozoite Surface Proteins 1 and 2 (msp-1 and msp-2) and Glutamate-Rich Protein (glurp) Genes
by
Muharib Alruwaili, Abozer Y. Elderdery, Hasan Ejaz, Aisha Farhana, Muhammad Atif, Hayfa Almutary and Jeremy Mills
Trop. Med. Infect. Dis. 2024, 9(11), 284; https://doi.org/10.3390/tropicalmed9110284 - 20 Nov 2024
Abstract
Resistance to current antimalarial drugs is steadily increasing, and new drugs are required. Drug efficacy trials remain the gold standard to assess the effectiveness of a given drug. The World Health Organization (WHO)’s recommendation for the optimal duration of follow-up for assessing antimalarial
[...] Read more.
Resistance to current antimalarial drugs is steadily increasing, and new drugs are required. Drug efficacy trials remain the gold standard to assess the effectiveness of a given drug. The World Health Organization (WHO)’s recommendation for the optimal duration of follow-up for assessing antimalarial efficacy is a minimum of 28 days. However, assessing antimalarial drug efficacy in highly endemic regions can be challenging due to the potential risks of acquiring a new infection in the follow-up period, and thus, it may underestimate the efficacy of the given drugs. A new treatment should be introduced if treatment failure rates exceed 10%. Overestimation occurs as a result of retaining a drug with a clinical efficacy of less than 90% with increases in morbidity and mortality, while underestimation may occur due to a misclassification of new infections as treatment failures with tremendous clinical and economic implications. Therefore, molecular genotyping is necessary to distinguish true new infections from treatment failures to ensure accuracy in determining antimalarial efficacy. There are three genetic markers that are commonly used in antimalarial efficiency trials to discriminate between treatment failures and new infections. These include merozoite surface protein 1 (msp-1), merozoite surface protein 2 (msp-2), and glutamate-rich protein (glurp). The genotyping of P. falciparum by nested polymerase chain reaction (n-PCR) targeting these markers is discussed with the inherent limitations and uncertainties associated with the PCR technique and limitations enforced by the parasite’s biology itself.
Full article
(This article belongs to the Special Issue The Global Burden of Malaria and Control Strategies)
►▼
Show Figures
Figure 1
Figure 1
<p>Diagrammatic representation of <span class="html-italic">msp-1</span> gene of <span class="html-italic">P. falciparum</span>.</p> Full article ">Figure 2
<p>Diagrammatic representation of <span class="html-italic">msp-2</span> gene of <span class="html-italic">P. falciparum</span>.</p> Full article ">Figure 3
<p>Diagrammatic representation of <span class="html-italic">glurp</span> gene of <span class="html-italic">P. falciparum</span>.</p> Full article ">
<p>Diagrammatic representation of <span class="html-italic">msp-1</span> gene of <span class="html-italic">P. falciparum</span>.</p> Full article ">Figure 2
<p>Diagrammatic representation of <span class="html-italic">msp-2</span> gene of <span class="html-italic">P. falciparum</span>.</p> Full article ">Figure 3
<p>Diagrammatic representation of <span class="html-italic">glurp</span> gene of <span class="html-italic">P. falciparum</span>.</p> Full article ">
Open AccessArticle
Evaluation of Serological Tests for Different Disease Stages of Leptospirosis Infection in Humans
by
Virginia C. Rodríguez-Rodriguez, Ana María Castro, Ronald Soto-Florez, Luis Urango-Gallego, Alfonso Calderón-Rangel, Piedad Agudelo-Flórez and Fernando P. Monroy
Trop. Med. Infect. Dis. 2024, 9(11), 283; https://doi.org/10.3390/tropicalmed9110283 - 20 Nov 2024
Abstract
Background/Objectives: Leptospirosis is a zoonotic disease that is widely distributed around the world and presents symptoms similar to other febrile illnesses in tropical regions, which complicates clinical diagnosis. This study aimed to evaluate the performance and agreement between serological diagnostic tests for detecting
[...] Read more.
Background/Objectives: Leptospirosis is a zoonotic disease that is widely distributed around the world and presents symptoms similar to other febrile illnesses in tropical regions, which complicates clinical diagnosis. This study aimed to evaluate the performance and agreement between serological diagnostic tests for detecting both acute and convalescent human leptospirosis, using the micro agglutination test (MAT) as a reference in an endemic region of the Colombian Caribbean. Methods: A prospective descriptive study was conducted on 275 participants with suspected leptospirosis. Paired serum samples were obtained, and an epidemiological survey was conducted. Using the MAT as the gold standard, we calculated positive and negative predictive values, sensitivity, specificity, and kappa index. A Bayesian latent class model was also used to compare the diagnostic tests. Results: In 223 paired serum samples, the sensitivity values for various stages of the disease ranged between 10.8% to 54.1% in the acute and 6.1% to 66.7% during the convalescent phase compared to the MAT. According to the Bayesian model, sensitivity was 9.5% to 75.3% in the acute phase and 5.7% to 85.3% in the convalescent phase. The Kappa value, an indicator of agreement, was moderate for the IgM ELISA in the acute phase (0.553) and substantial in the convalescent phase (0.692). Conclusions: The MAT was the best confirmatory test in both acute and convalescent phases of leptospirosis. Despite the high specificity of ELISA, 21.62% of participants identified as negative by IgM-ELISA in both phases were subsequently confirmed as positive by the MAT. It is necessary to re-evaluate diagnostic guidelines that do not employ the MAT for confirmation and to enhance the diagnostic and clinical identification of leptospirosis within healthcare institutions and public health laboratories while providing a rapid and reliable test for its implementation.
Full article
(This article belongs to the Special Issue Advances in Molecular Diagnosis in Neglected Tropical Diseases)
Open AccessArticle
Surveillance of Emerging Rodent-Borne Pathogens in Wastewater in Taiwan: A One Health Approach
by
Kun-Hsien Tsai, Tsai-Ying Yen, Hsin-Hsin Tung, Amy Ho, Yang-Ta Chien, Chung-Yu Wang, Shu-Wei Kang, Ning-Ning Juan and Fang-Ling Lin
Trop. Med. Infect. Dis. 2024, 9(11), 282; https://doi.org/10.3390/tropicalmed9110282 - 18 Nov 2024
Abstract
Leptospirosis and hantavirus syndrome are two major rodent-borne diseases in Taiwan. Rocahepevirus ratii (RHEV), a virus closely related to hepatitis E virus (HEV, Paslahepevirus balayani), is emerging and has been reported to cause hepatitis in humans. We employed wastewater-based epidemiology to actively
[...] Read more.
Leptospirosis and hantavirus syndrome are two major rodent-borne diseases in Taiwan. Rocahepevirus ratii (RHEV), a virus closely related to hepatitis E virus (HEV, Paslahepevirus balayani), is emerging and has been reported to cause hepatitis in humans. We employed wastewater-based epidemiology to actively monitor rodent-borne pathogens, and the correlations with human cases were evaluated. Wastewater was collected using grab sampling at 11 sites along a sewer system including influents and effluents at a wastewater treatment plant in Tamsui, New Taipei City, Taiwan, monthly during June 2023 to May 2024. The presence of pathogens was examined by reverse transcription-polymerase chain reaction (RT-PCR). The result showed an overall positivity rate of 38.2% (50/131). Leptospira was detected most often (48/131, 36.6%), and RHEV and hantaviruses were found once each during the study period. Sequencing identified Leptospira interrogans close to isolates from rodents and human cases, while sequences of hantavirus and RHEV were most similar to isolates from rodents. No significant correlation was found with human cases or positive samples for rodent DNA. Here, we present an example of a One Health approach applying wastewater to environmental surveillance for the early detection and prevention of emerging diseases.
Full article
(This article belongs to the Special Issue Leptospirosis and One Health Approach: Current Status and Future Prospects, 2nd Edition)
►▼
Show Figures
Figure 1
Figure 1
<p>The sampling sites of wastewater in Tamsui, New Taipei City, Taiwan.</p> Full article ">Figure 2
<p>(<b>a</b>) The phylogenetic analysis of <span class="html-italic">Leptospira</span> spp. based on the partial nucleotide sequence of secY (245 nt). <span class="html-italic">Leptospira borgpetersenii</span> was used for the outgroup species. The evolutionary relationships were inferred by a neighbor-joining method with 1000 bootstrap replicates. Sequences obtained in the study were written in bold, and the sampling sites and time were indicated. (<b>b</b>) The monthly positivity rates of <span class="html-italic">Leptospira</span> detected in wastewater and numbers of leptospirosis cases.</p> Full article ">Figure 3
<p>(<b>a</b>) The phylogenetic analysis of <span class="html-italic">Orthohantavirus seoulense</span> based on the partial nucleotide sequence of the M segment (160 nt). The evolutionary relationships were inferred by a neighbor-joining method with 1000 bootstrap replicates. (<b>b</b>) The phylogenetic analysis of hepeviruses based on the partial nucleotide sequence of ORF1 (279 nt). The evolutionary relationships were inferred by a neighbor-joining method with 1000 bootstrap replicates. Sequences obtained in the study were written in bold, and the sampling sites and time were indicated.</p> Full article ">
<p>The sampling sites of wastewater in Tamsui, New Taipei City, Taiwan.</p> Full article ">Figure 2
<p>(<b>a</b>) The phylogenetic analysis of <span class="html-italic">Leptospira</span> spp. based on the partial nucleotide sequence of secY (245 nt). <span class="html-italic">Leptospira borgpetersenii</span> was used for the outgroup species. The evolutionary relationships were inferred by a neighbor-joining method with 1000 bootstrap replicates. Sequences obtained in the study were written in bold, and the sampling sites and time were indicated. (<b>b</b>) The monthly positivity rates of <span class="html-italic">Leptospira</span> detected in wastewater and numbers of leptospirosis cases.</p> Full article ">Figure 3
<p>(<b>a</b>) The phylogenetic analysis of <span class="html-italic">Orthohantavirus seoulense</span> based on the partial nucleotide sequence of the M segment (160 nt). The evolutionary relationships were inferred by a neighbor-joining method with 1000 bootstrap replicates. (<b>b</b>) The phylogenetic analysis of hepeviruses based on the partial nucleotide sequence of ORF1 (279 nt). The evolutionary relationships were inferred by a neighbor-joining method with 1000 bootstrap replicates. Sequences obtained in the study were written in bold, and the sampling sites and time were indicated.</p> Full article ">
Open AccessArticle
Community Knowledge, Attitudes and Practices About Malaria: Insights from a Northwestern Colombian Endemic Locality
by
Paola Muñoz-Laiton, Juan C. Hernández-Valencia and Margarita M. Correa
Trop. Med. Infect. Dis. 2024, 9(11), 281; https://doi.org/10.3390/tropicalmed9110281 - 18 Nov 2024
Abstract
Malaria prevention and control programs are mainly oriented to vector control, timely diagnosis and adequate treatment. Malaria transmission is influenced by several factors, including biological and social aspects. Thus, it is relevant to consider community beliefs and practices to ensure sustainable prevention and
[...] Read more.
Malaria prevention and control programs are mainly oriented to vector control, timely diagnosis and adequate treatment. Malaria transmission is influenced by several factors, including biological and social aspects. Thus, it is relevant to consider community beliefs and practices to ensure sustainable prevention and control strategies. This study aimed to determine knowledge, attitudes and practices (KAP) towards malaria in an endemic locality in northwestern Colombia. Preliminary data were collected through a focus group discussion. Subsequently, a KAP survey was administered to the community. KAP scores were associated with both sociodemographic characteristics and with previous malaria infection. Focus group data revealed knowledge gaps and the absence of or having worn-out nets. Survey results showed that participants recognized a mosquito bite as the transmission mode (72.09%), followed by dirty water (44.19%), high fever (86.05%) and headache (79.07%) as the main symptoms. Regarding attitudes, 44.19% of the people would go to the hospital in the case of having symptoms. The most recognized practices for disease prevention were the use of mosquito nets (65.12%) and fans (23.26%). The results showed that some people had misconceptions about the disease transmission mode. The analysis showed significant associations of either female gender and homemaker occupation with a good knowledge [OR = 3.74, (p = 0.04), OR = 3.55, (p = 0.04), respectively] or female with a positive attitude towards malaria control and prevention [OR = 4.80, (p = 0.04)]. These results showed that the identified gaps in KAP require increasing education among the community in addition to applying public health prevention efforts. The data may be useful in designing malaria control strategies that involve community participation.
Full article
(This article belongs to the Special Issue Aspects of the Ecology and Biology of Malaria Vectors with Implications for Disease Prevention and Control)
►▼
Show Figures
Figure 1
Figure 1
<p>Study area. The left square shows the map of Colombia in relation to South America and the Bajo Cauca subregion in northwestern Colombia. The right square shows the Villa Grande locality in the BC subregion.</p> Full article ">Figure 2
<p>Diagram of categories and subcategories established after qualitative analysis of the focus group discussion.</p> Full article ">
<p>Study area. The left square shows the map of Colombia in relation to South America and the Bajo Cauca subregion in northwestern Colombia. The right square shows the Villa Grande locality in the BC subregion.</p> Full article ">Figure 2
<p>Diagram of categories and subcategories established after qualitative analysis of the focus group discussion.</p> Full article ">
Open AccessReview
A Risk Management Approach to Global Pandemics of Infectious Disease and Anti-Microbial Resistance
by
Annie Sparrow, Meghan Smith-Torino, Samuel M. Shamamba, Bisimwa Chirakarhula, Maranatha A. Lwaboshi, Christine Stabell Benn and Konstantin Chumakov
Trop. Med. Infect. Dis. 2024, 9(11), 280; https://doi.org/10.3390/tropicalmed9110280 - 18 Nov 2024
Abstract
Pandemics of infectious disease and growing anti-microbial resistance (AMR) pose major threats to global health, trade, and security. Conflict and climate change compound and accelerate these threats. The One Health approach recognizes the interconnectedness of human, animal, and environmental health, but is grounded
[...] Read more.
Pandemics of infectious disease and growing anti-microbial resistance (AMR) pose major threats to global health, trade, and security. Conflict and climate change compound and accelerate these threats. The One Health approach recognizes the interconnectedness of human, animal, and environmental health, but is grounded in the biomedical model, which reduces health to the absence of disease. Biomedical responses are insufficient to meet the challenges. The COVID-19 pandemic is the most recent example of the failure of this biomedical model to address global threats, the limitations of laboratory-based surveillance, and the exclusive focus on vaccination for disease control. This paper examines the current paradigm through the lens of polio and the global campaign to eradicate it, as well as other infectious threats including mpox and drug-resistant tuberculosis, particularly in the context of armed conflict. Decades before vaccines became widely available, public health measures—ventilation, chlorination, nutrition and sanitation— led to longer, healthier, and even taller lives. Chlorine, our primary tool of public health, conquered cholera and transformed infection control in hospitals. The World Health Organization (WHO), part of the One Health alliance, focuses mainly on antibiotics and vaccines to reduce deaths due to superbugs and largely ignores the critical role of chlorine to control water-borne diseases (including polio) and other infections. Moreover, the One Health approach ignores armed conflict. Contemporary wars are characterized by indiscriminate bombing of civilians, attacks targeting healthcare, mass displacement and lack of humanitarian access, conditions which drive polio outbreaks and incubate superbugs. We discuss the growing trend of attacks on healthcare and differentiate between types: community-driven attacks targeting vaccinators in regions like Pakistan, and state-sponsored attacks by governments such as those of Syria and Russia that weaponize healthcare to deliberately harm whole populations. Both fuel outbreaks of disease. These distinct motivations necessitate tailored responses, yet the WHO aggregates these attacks in a manner that hampers effective intervention. While antimicrobial resistance is predictable, the escalating pandemic is the consequence of our reliance on antibiotics and commitment to a biomedical model that now borders on pathological. Our analysis reveals the international indenture to the biomedical model as the basis of disease control is the root driver of AMR and vaccine-derived polio. The unique power of vaccines is reduced by vaccination-only strategy, and in fact breeds vaccine-derived polio. The non-specific effects of vaccines must be leveraged, and universal vaccination must be supplemented by international investment in water chlorination. This will reduce health costs and strengthen global health security. While vaccines are an important weapon to combat pandemics and AMR, they must be accompanied by the entire arsenal of public health interventions.
Full article
(This article belongs to the Special Issue Pathogen-Host-Environment Interactions: One-Health Perspectives and Solutions in Antimicrobial Resistance and Disease)
►▼
Show Figures
Figure 1
Open AccessArticle
Severity of Vessel Color Changes and Macular and Peripheral Whitening in Malarial Retinopathy Are Associated with Higher Total Body and Sequestered Parasite Burdens
by
Chiadika Nwanze, Daniel Muller, Priscilla Suleman, Mrinmayee Takle, John R. Barber, Kyle J. Wilson, Nicholas A. V. Beare, Karl B. Seydel and Douglas G. Postels
Trop. Med. Infect. Dis. 2024, 9(11), 279; https://doi.org/10.3390/tropicalmed9110279 - 16 Nov 2024
Abstract
Two-thirds of children with cerebral malaria (CM) exhibit retinopathy characterized by whitening, vessel color changes, and/or hemorrhages. The pathogenesis of malarial retinopathy is not fully understood. This study aimed to assess the relationship between malarial retinopathy and the severity of its components (macular
[...] Read more.
Two-thirds of children with cerebral malaria (CM) exhibit retinopathy characterized by whitening, vessel color changes, and/or hemorrhages. The pathogenesis of malarial retinopathy is not fully understood. This study aimed to assess the relationship between malarial retinopathy and the severity of its components (macular whitening, retinal hemorrhages, and vessel color changes) with the total, circulating, or sequestered parasite load in children with CM. Total parasite burden was estimated by measuring plasma levels of Plasmodium falciparum histidine-rich protein 2 (PfHRP2), while the sequestered load was calculated as the difference between the total burden and circulating parasitemia. Children with retinopathy-positive CM (n = 172) had higher total and sequestered parasite burdens compared to retinopathy-negative children (n = 42) (both p = 0.049). In a subgroup with detailed retinopathy grading (n = 52), more extensive vessel color changes correlated with higher total, sequestered, and circulating parasite loads (p = 0.0057, p = 0.0068, and p = 0.0433, respectively). Peripheral retinal whitening was also associated with increased total and sequestered loads (p = 0.0017 and p = 0.0012). No association was found between retinal hemorrhages and parasite burden, indicating that other factors may influence their pathogenesis.
Full article
(This article belongs to the Special Issue Recent Progress in Mosquito-Borne Diseases)
►▼
Show Figures
Figure 1
Figure 1
<p>Association of total body parasite burden with severity of vessel color changes (<b>A</b>), peripheral whitening (<b>B</b>), macular whitening (<b>C</b>), and retinal hemorrhages (<b>D</b>). log (tbp qHRP-2): logarithm of total body parasite burden as determined by analysis of blood quantitative histidine-rich protein 2. <sup>1</sup> Vessel changes are graded as no (0) or yes (1) in each quadrant of both eyes, divided by the number of quadrants visualized, with a mean taken between the eyes. <sup>2</sup> Peripheral whitening is graded as absent (0), mild (1), moderate (2), or severe (3). Grade 3 peripheral whitening must be a widespread mosaic or have patches of confluence. <sup>3</sup> Macular whitening is graded as absent (0), less than one-third disc (optic nerve) area in diameter (1), one-third to one disc area in diameter (2), greater than one disc area in diameter (3), with a mean taken between the two eyes. <sup>4</sup> Retinal hemorrhages are graded as absent (0), 1–5 hemorrhages (1), 6–20 hemorrhages (2), 21–50 hemorrhages (3), or 51 or more hemorrhages (4).</p> Full article ">Figure 2
<p>Association of sequestered parasite burden with severity of vessel color changes (<b>A</b>), peripheral whitening (<b>B</b>), macular whitening (<b>C</b>), and retinal hemorrhages (<b>D</b>). Log (seq qHRP-2): logarithm of sequestered parasite load as determined by estimating total body parasite burden using quantitative histidine-rich protein 2 and subtracting circulating parasite burden. <sup>1</sup> Vessel changes are graded as no (0) or yes (1) in each quadrant of both eyes, divided by the number of quadrants visualized, with a mean taken between the eyes. <sup>2</sup> Peripheral whitening is graded as absent (0), mild (1), moderate (2), or severe (3). Grade 3 peripheral whitening must be a widespread mosaic or have patches of confluence. <sup>3</sup> Macular whitening is graded as absent (0), less than one-third disc (optic nerve) area in diameter (1), one-third to one disc area in diameter (2), greater than one disc area in diameter (3), with a mean taken between the two eyes. <sup>4</sup> Retinal hemorrhages are graded as absent (0), 1–5 hemorrhages (1), 6–20 hemorrhages (2), 21–50 hemorrhages (3), or 51 or more hemorrhages (4).</p> Full article ">Figure 2 Cont.
<p>Association of sequestered parasite burden with severity of vessel color changes (<b>A</b>), peripheral whitening (<b>B</b>), macular whitening (<b>C</b>), and retinal hemorrhages (<b>D</b>). Log (seq qHRP-2): logarithm of sequestered parasite load as determined by estimating total body parasite burden using quantitative histidine-rich protein 2 and subtracting circulating parasite burden. <sup>1</sup> Vessel changes are graded as no (0) or yes (1) in each quadrant of both eyes, divided by the number of quadrants visualized, with a mean taken between the eyes. <sup>2</sup> Peripheral whitening is graded as absent (0), mild (1), moderate (2), or severe (3). Grade 3 peripheral whitening must be a widespread mosaic or have patches of confluence. <sup>3</sup> Macular whitening is graded as absent (0), less than one-third disc (optic nerve) area in diameter (1), one-third to one disc area in diameter (2), greater than one disc area in diameter (3), with a mean taken between the two eyes. <sup>4</sup> Retinal hemorrhages are graded as absent (0), 1–5 hemorrhages (1), 6–20 hemorrhages (2), 21–50 hemorrhages (3), or 51 or more hemorrhages (4).</p> Full article ">Figure 3
<p>Association of circulating parasite burden with severity of vessel color changes (<b>A</b>), peripheral whitening (<b>B</b>), macular whitening (<b>C</b>), and retinal hemorrhages (<b>D</b>). Log (parasitemia): logarithm of circulating parasite burden. <sup>1</sup> Vessel changes are graded as no (0) or yes (1) in each quadrant of both eyes, divided by the number of quadrants visualized, with a mean taken between the eyes. <sup>2</sup> Peripheral whitening is graded as absent (0), mild (1), moderate (2), or severe (3). Grade 3 peripheral whitening must be a widespread mosaic or have patches of confluence. <sup>3</sup> Macular whitening is graded as absent (0), less than one-third disc (optic nerve) area in diameter (1), one-third to one disc area in diameter (2), greater than one disc area in diameter (3), with a mean taken between the two eyes. <sup>4</sup> Retinal hemorrhages are graded as absent (0), 1–5 hemorrhages (1), 6–20 hemorrhages (2), 21–50 hemorrhages (3), or 51 or more hemorrhages (4).</p> Full article ">
<p>Association of total body parasite burden with severity of vessel color changes (<b>A</b>), peripheral whitening (<b>B</b>), macular whitening (<b>C</b>), and retinal hemorrhages (<b>D</b>). log (tbp qHRP-2): logarithm of total body parasite burden as determined by analysis of blood quantitative histidine-rich protein 2. <sup>1</sup> Vessel changes are graded as no (0) or yes (1) in each quadrant of both eyes, divided by the number of quadrants visualized, with a mean taken between the eyes. <sup>2</sup> Peripheral whitening is graded as absent (0), mild (1), moderate (2), or severe (3). Grade 3 peripheral whitening must be a widespread mosaic or have patches of confluence. <sup>3</sup> Macular whitening is graded as absent (0), less than one-third disc (optic nerve) area in diameter (1), one-third to one disc area in diameter (2), greater than one disc area in diameter (3), with a mean taken between the two eyes. <sup>4</sup> Retinal hemorrhages are graded as absent (0), 1–5 hemorrhages (1), 6–20 hemorrhages (2), 21–50 hemorrhages (3), or 51 or more hemorrhages (4).</p> Full article ">Figure 2
<p>Association of sequestered parasite burden with severity of vessel color changes (<b>A</b>), peripheral whitening (<b>B</b>), macular whitening (<b>C</b>), and retinal hemorrhages (<b>D</b>). Log (seq qHRP-2): logarithm of sequestered parasite load as determined by estimating total body parasite burden using quantitative histidine-rich protein 2 and subtracting circulating parasite burden. <sup>1</sup> Vessel changes are graded as no (0) or yes (1) in each quadrant of both eyes, divided by the number of quadrants visualized, with a mean taken between the eyes. <sup>2</sup> Peripheral whitening is graded as absent (0), mild (1), moderate (2), or severe (3). Grade 3 peripheral whitening must be a widespread mosaic or have patches of confluence. <sup>3</sup> Macular whitening is graded as absent (0), less than one-third disc (optic nerve) area in diameter (1), one-third to one disc area in diameter (2), greater than one disc area in diameter (3), with a mean taken between the two eyes. <sup>4</sup> Retinal hemorrhages are graded as absent (0), 1–5 hemorrhages (1), 6–20 hemorrhages (2), 21–50 hemorrhages (3), or 51 or more hemorrhages (4).</p> Full article ">Figure 2 Cont.
<p>Association of sequestered parasite burden with severity of vessel color changes (<b>A</b>), peripheral whitening (<b>B</b>), macular whitening (<b>C</b>), and retinal hemorrhages (<b>D</b>). Log (seq qHRP-2): logarithm of sequestered parasite load as determined by estimating total body parasite burden using quantitative histidine-rich protein 2 and subtracting circulating parasite burden. <sup>1</sup> Vessel changes are graded as no (0) or yes (1) in each quadrant of both eyes, divided by the number of quadrants visualized, with a mean taken between the eyes. <sup>2</sup> Peripheral whitening is graded as absent (0), mild (1), moderate (2), or severe (3). Grade 3 peripheral whitening must be a widespread mosaic or have patches of confluence. <sup>3</sup> Macular whitening is graded as absent (0), less than one-third disc (optic nerve) area in diameter (1), one-third to one disc area in diameter (2), greater than one disc area in diameter (3), with a mean taken between the two eyes. <sup>4</sup> Retinal hemorrhages are graded as absent (0), 1–5 hemorrhages (1), 6–20 hemorrhages (2), 21–50 hemorrhages (3), or 51 or more hemorrhages (4).</p> Full article ">Figure 3
<p>Association of circulating parasite burden with severity of vessel color changes (<b>A</b>), peripheral whitening (<b>B</b>), macular whitening (<b>C</b>), and retinal hemorrhages (<b>D</b>). Log (parasitemia): logarithm of circulating parasite burden. <sup>1</sup> Vessel changes are graded as no (0) or yes (1) in each quadrant of both eyes, divided by the number of quadrants visualized, with a mean taken between the eyes. <sup>2</sup> Peripheral whitening is graded as absent (0), mild (1), moderate (2), or severe (3). Grade 3 peripheral whitening must be a widespread mosaic or have patches of confluence. <sup>3</sup> Macular whitening is graded as absent (0), less than one-third disc (optic nerve) area in diameter (1), one-third to one disc area in diameter (2), greater than one disc area in diameter (3), with a mean taken between the two eyes. <sup>4</sup> Retinal hemorrhages are graded as absent (0), 1–5 hemorrhages (1), 6–20 hemorrhages (2), 21–50 hemorrhages (3), or 51 or more hemorrhages (4).</p> Full article ">
Open AccessEditorial
Renewing Our Focus on Vulnerable Populations Among People Living with HIV
by
James Ayieko, Marguerite Thorp and Musie Ghebremichael
Trop. Med. Infect. Dis. 2024, 9(11), 278; https://doi.org/10.3390/tropicalmed9110278 - 14 Nov 2024
Abstract
The global HIV landscape has changed over the past few decades, with great milestones achieved in both HIV treatment and prevention [...]
Full article
(This article belongs to the Special Issue Living with HIV: Support, Care, and Treatment for Vulnerable Populations)
Journal Menu
► ▼ Journal Menu-
- TropicalMed Home
- Aims & Scope
- Editorial Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserHighly Accessed Articles
Latest Books
E-Mail Alert
News
Topics
Conferences
Special Issues
Special Issue in
TropicalMed
The Epidemiology, Diagnosis and Treatment of Foodborne and Waterborne Diseases
Guest Editor: Anita NovakDeadline: 24 December 2024
Special Issue in
TropicalMed
Gender in Infectious Diseases: Impact and Perspectives
Guest Editor: Lynn Lieberman LawryDeadline: 31 December 2024
Special Issue in
TropicalMed
Progress in Pneumonia and Pneumococcal Research
Guest Editor: Bhim Gopal DhoubhadelDeadline: 31 December 2024
Special Issue in
TropicalMed
Zoonotic Parasitic Diseases: Emerging Issues and Problems
Guest Editors: Vinícius Longo Ribeiro Vilela, Thais Ferreira FeitosaDeadline: 31 December 2024
Topical Collections
Topical Collection in
TropicalMed
Infection Prevention and Control: Practical and Educational Advances
Collection Editors: Constantinos Tsioutis, Spyridon Karageorgos, Nico Mutters, Carlos Palos